Sol-Gel N2B for Parkinson’s
Reading Time: 3 minutes
Parkinson’s disease is a complex neurodegenerative disorder that requires ongoing advances in pharmaceutical research to improve patient outcomes. Recent developments by PreveCeutical have focused on the Sol-Gel N2B platform, a …
Day-to-Day PD Variability
Reading Time: 4 minutes
Parkinson’s disease (PD), motor symptom variability, MDS-UPDRS scale, day-to-day changes, clinically meaningful fluctuations, crossover design, continuous monitoring, wearable sensors, digital biomarkers, patient-centric approach, non-motor symptoms, reliability, clinical trials, disease management, …
Mucuna Pruriens for Parkinson’s
Reading Time: 3 minutes
Parkinson’s disease (PD) is a neurodegenerative disorder that results from dopamine depletion in the brain. Traditional treatment relies heavily on levodopa (L-DOPA), the gold standard for managing motor symptoms. However, …
Read MoreTsunami of baby boomers developing PD
Reading Time: 3 minutes
A recent wave of research and medical observations indicates a tsunami of baby boomers developing Parkinson’s disease (PD). As the population ages, the number of individuals diagnosed with PD is …
Parkinson’s Symptom Tracking: A Game-Changer for Patients & Clinicians
Reading Time: 3 minutes
Introduction
Parkinson’s disease affects over 10 million people worldwide, causing motor and non-motor symptoms that impact daily life. Tracking these symptoms effectively is crucial for optimizing treatment and improving quality of …
Read More